MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

MDT

98.5

+2.11%↑

A

146.08

-0.25%↓

VEEV

218.2

-4.44%↓

HQY

85.69

+1.95%↑

NEOG

9.39

+2.4%↑

Search

ResMed Inc

Geschlossen

BrancheGesundheitswesen

259.78 1.9

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

251.28

Max

259.96

Schlüsselkennzahlen

By Trading Economics

Einkommen

-31M

349M

Verkäufe

-12M

1.3B

KGV

Branchendurchschnitt

26.391

90.831

Dividendenrendite

0.87

Gewinnspanne

26.096

Angestellte

10,600

EBITDA

-29M

503M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+15.44% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.87%

2.20%

Nächstes Ergebnis

29. Jan. 2026

Nächste Dividendenausschüttung

19. März 2026

Nächstes Ex-Dividendendatum

12. Feb. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-193M

38B

Vorheriger Eröffnungskurs

257.88

Vorheriger Schlusskurs

259.78

Nachrichtenstimmung

By Acuity

33%

67%

68 / 361 Ranking in Healthcare

ResMed Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

14. Jan. 2026, 22:41 UTC

Akquisitionen, Fusionen, Übernahmen

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

15. Jan. 2026, 00:00 UTC

Ergebnisse

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

14. Jan. 2026, 23:47 UTC

Market Talk

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

14. Jan. 2026, 23:44 UTC

Market Talk

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

14. Jan. 2026, 23:39 UTC

Market Talk

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

14. Jan. 2026, 23:32 UTC

Market Talk

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

14. Jan. 2026, 22:56 UTC

Akquisitionen, Fusionen, Übernahmen

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

14. Jan. 2026, 22:53 UTC

Akquisitionen, Fusionen, Übernahmen

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

14. Jan. 2026, 22:17 UTC

Market Talk

Global Equities Roundup: Market Talk

14. Jan. 2026, 22:17 UTC

Market Talk

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

14. Jan. 2026, 22:09 UTC

Ergebnisse

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

14. Jan. 2026, 22:08 UTC

Ergebnisse

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

14. Jan. 2026, 22:08 UTC

Ergebnisse

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

14. Jan. 2026, 21:53 UTC

Akquisitionen, Fusionen, Übernahmen

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

14. Jan. 2026, 21:53 UTC

Akquisitionen, Fusionen, Übernahmen

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

14. Jan. 2026, 21:52 UTC

Akquisitionen, Fusionen, Übernahmen

WuXi XDC Announces Positive Profit Alert for 2025

14. Jan. 2026, 21:51 UTC

Akquisitionen, Fusionen, Übernahmen

Citigroup Acting as Financial Advisor to WuXi XDC

14. Jan. 2026, 21:51 UTC

Akquisitionen, Fusionen, Übernahmen

WuXi XDC: Aims to Keep Listing Status of BioDlink

14. Jan. 2026, 21:51 UTC

Akquisitionen, Fusionen, Übernahmen

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

14. Jan. 2026, 21:50 UTC

Market Talk
Ergebnisse

Financial Services Roundup: Market Talk

14. Jan. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14. Jan. 2026, 21:49 UTC

Akquisitionen, Fusionen, Übernahmen

WuXi XDC: BioDlink Offer to Cost HK$2.79B

14. Jan. 2026, 21:48 UTC

Akquisitionen, Fusionen, Übernahmen

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

14. Jan. 2026, 21:48 UTC

Akquisitionen, Fusionen, Übernahmen

WuXi XDC Makes Cash Offer for BioDlink International

14. Jan. 2026, 21:13 UTC

Market Talk

Oil Retreats Late After Trump Comments on Iran -- Market Talk

14. Jan. 2026, 20:30 UTC

Market Talk
Ergebnisse

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

14. Jan. 2026, 20:13 UTC

Market Talk

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

14. Jan. 2026, 20:08 UTC

Market Talk

Oil Futures Extend Rally on Iran Tensions -- Market Talk

14. Jan. 2026, 19:33 UTC

Market Talk

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

14. Jan. 2026, 19:06 UTC

Market Talk
Ergebnisse

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Peer-Vergleich

Kursveränderung

ResMed Inc Prognose

Kursziel

By TipRanks

15.44% Vorteil

12-Monats-Prognose

Durchschnitt 294 USD  15.44%

Hoch 345 USD

Tief 260 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für ResMed Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

11 ratings

6

Buy

5

Halten

0

Sell

Stimmung

By Acuity

68 / 361 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat